Codes / ICD10CM / F18.20

F18.20 Inhalant dependence, uncomplicated

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Inhalant Dependence, Uncomplicated
  • Medical Term: Inhalant Dependence, Uncomplicated

Summary

Inhalant dependence, uncomplicated, is a substance use disorder characterized by a problematic pattern of inhalant use leading to clinically significant impairment or distress. It involves a combination of physiological, behavioral, and cognitive symptoms related to continued use despite adverse consequences. This condition may include tolerance, withdrawal, and compulsive use, impacting physical health, mental functioning, and daily life without additional complicating factors.

Causes

Inhalant dependence develops from repeated misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects. Inhalants are often common household or industrial products, such as glue, paint thinners, aerosols, or solvents. Prolonged use can alter brain chemistry, leading to dependence and related health issues.

Risk Factors

  • Adolescents and young adults are more likely to experiment with inhalants.
  • Individuals with a history of substance abuse or mental health disorders.
  • Accessibility to inhalant products.
  • Lack of proper supervision or guidance.

Symptoms

  • Intense cravings or compulsive inhalant use.
  • Coordination problems, dizziness, or lethargy.
  • Unexplained behavioral changes such as aggression or mood swings.
  • Cognitive impairment or memory issues.
  • Withdrawal symptoms when use is reduced or stopped.

Diagnosis

Clinical evaluation including a detailed history of inhalant use, physical examination, and assessment of symptoms. Laboratory tests may be used to rule out other conditions, but diagnosis primarily relies on clinical criteria.

Treatment Options

Treatment may include behavioral therapies, such as cognitive-behavioral therapy, to address psychological aspects of dependence. Supportive care and monitoring for withdrawal symptoms are often necessary. In some cases, medication may be used to manage withdrawal or co-occurring conditions.

Prognosis and Follow-Up

Prognosis varies depending on the severity of dependence and individual circumstances. Long-term follow-up is important to monitor for relapse and address ongoing needs. Recovery may involve sustained behavioral changes and support.

Complications

Complications can include organ damage (e.g., liver, kidney), neurological issues, and increased risk of accidents due to impaired coordination. Chronic use may also lead to cognitive decline or mental health disorders.

Lifestyle & Prevention

Avoiding inhalant use and educating individuals about the risks can help prevent dependence. Promoting healthy coping mechanisms and providing access to supportive resources may reduce the likelihood of misuse.

When to Seek Professional Help

Seek professional help if there are signs of inhalant dependence, such as inability to stop use, withdrawal symptoms, or significant impairment in daily life. Early intervention can improve outcomes.

Tips for Medical Coders

Document the presence of inhalant dependence and confirm the absence of complicating factors to support the use of F18.20. Ensure clinical notes reflect the uncomplicated nature of the condition for accurate coding.

Book a walkthrough

F18.20 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.